Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Upcoming SlideShare
Loading in …5
×

The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

336 views

Published on

SummaryThe author has released its latest research 'The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis.' The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global CNS diseases therapeutics market. The report analyzes the markets for CNS disease therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2015 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets.This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.ScopeThe scope of this report includes:- Annualized market data for the CNS diseases therapeutics market from 2000 to 2008, forecast forward to 2015- Analysis of the leading therapeutic segments including Alzheimer's disease, Parkinson's disease, Schizophrenia and Bipolar Disorder, Epilepsy, Major depressive disorder (MDD), anxiety and panic disorder, Attention Deficit Hyperactivity Disorder (ADHD) and Insomnia.- Analysis of the CNS diseases therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan - Market characterization of the CNS diseases therapeutics market including market size, annual cost of therapy, sales volume and treatment usage patterns - Key drivers and barriers that have a significant impact on the market - Coverage of pipeline molecules in various phases of drug development - Competitive benchmarking of leading companies. The key companies studied in this report are F.Hoffmann-La Roche, Novartis AG, Sanofi-aventis, Lundbeck A/S, AstraZeneca, Merck & Co, Pfizer Inc, UCB S.A., Bristol-Myers Squibb and Eli Lilly- Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global CNS diseases therapeutics marketReasons to buyThe report will enhance your decision making capability. It will allow you to- Align product portfolio to the markets with high growth potential- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth - Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety- Develop key strategic initiatives by understanding key focus areas of leading companies - Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

Published in: Business, News & Politics
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
336
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

  1. 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!The Future of Central Nervous System Diseases Therapeutics -Market Forecasts to 2015, Competitive Benchmarking, ProductPipeline and Deals AnalysisPublished on December 2009 Report SummarySummaryThe author has released its latest research The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to2015, Competitive Benchmarking, Product Pipeline and Deals Analysis. The report provides in-depth analysis of unmet needs,drivers and barriers that impact the global CNS diseases therapeutics market. The report analyzes the markets for CNS diseasetherapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usagepatterns, sales, price and volume are forecast until 2015 for the key geographies as well as the leading therapeutic segments.Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions andlicensing agreements that shape the global markets.This report is built using data and information sourced from proprietary databases, primary and secondary research and in-houseanalysis by GBI Researchs team of industry experts.ScopeThe scope of this report includes:- Annualized market data for the CNS diseases therapeutics market from 2000 to 2008, forecast forward to 2015- Analysis of the leading therapeutic segments including Alzheimers disease, Parkinsons disease, Schizophrenia and BipolarDisorder, Epilepsy, Major depressive disorder (MDD), anxiety and panic disorder, Attention Deficit Hyperactivity Disorder (ADHD) andInsomnia.- Analysis of the CNS diseases therapeutics market in the leading geographies of the world, which include the US, the UK, Germany,France, Italy, Spain, and Japan- Market characterization of the CNS diseases therapeutics market including market size, annual cost of therapy, sales volume andtreatment usage patterns- Key drivers and barriers that have a significant impact on the market- Coverage of pipeline molecules in various phases of drug development- Competitive benchmarking of leading companies. The key companies studied in this report are F.Hoffmann-La Roche, Novartis AG,Sanofi-aventis, Lundbeck A/S, AstraZeneca, Merck & Co, Pfizer Inc, UCB S.A., Bristol-Myers Squibb and Eli Lilly- Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global CNS diseases therapeuticsmarketReasons to buyThe report will enhance your decision making capability. It will allow you to- Align product portfolio to the markets with high growth potential- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic marketspoised for strong growthThe Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 1/15
  2. 2. Find Industry reports, Company profilesReportLinker and Market Statistics- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency andbetter safety- Develop key strategic initiatives by understanding key focus areas of leading companies- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps Table of Content1 Table of Contents1 Table of Contents 41.1 List of Tables 91.2 List of Figures 152 Global CNS Therapeutics Market : Introduction 202.1 Disease Overview 202.2 GBI Research Report Guidance 203 Global CNS Therapeutics Market: Market Characterization 223.1 Market Overview 223.2 Market Forecasts 243.3 Branded Versus Generics 253.4 Market Share by Disease Sectors 263.5 Average Cost of Therapy 263.6 Volume 283.7 Usage Patterns 293.7.1 Diseased Population 293.7.2 Treatment Seeking Population 303.7.3 Diagnosis Population 313.7.4 Prescription Population 323.7.5 Therapeutic Usage Patterns 333.8 Geographical Distribution 343.9 Market Drivers and Restraints 363.9.1 Market Drivers 363.9.2 Market Restraints 373.10 Unmet Needs 393.10.1 Alzheimers Disease 403.10.2 Parkinsons Disease 403.10.3 Schizophrenia and bipolar Disorder 403.10.4 Depression 403.10.5 Insomnia 403.11 Key Market Trends 413.11.1 Increase in Disease Incidence and Prevalence Rates 413.11.2 Product Pipeline 413.11.3 Advertising and Commercialization 423.11.4 Regulatory trends Current Reimbursement Scenario 424 Global Alzheimers Disease Therapeutics Market 444.1 Market Overview 444.2 Market Forecasts 444.3 Average Cost of Therapy 454.4 Volume 464.5 Usage Patterns 48The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 2/15
  3. 3. Find Industry reports, Company profilesReportLinker and Market Statistics4.5.1 Diseased Population 484.5.2 Treatment Seeking Population 494.5.3 Diagnosis Population 504.5.4 Prescription Population 514.5.5 Therapeutic Usage Patterns 524.6 Product Analysis 534.6.1 Aricept 534.6.2 Exelon and Exelon Patch 544.6.3 Ebixa (Namenda) 554.6.4 Razadyne and Reminyl 554.7 Drug Pipeline Analysis 555 Global Parkinsons Disease Therapeutics Market 595.1 Market Overview 595.2 Market Forecasts 595.3 Average Cost of Therapy 615.4 Volume 625.5 Usage Patterns 635.5.1 Diseased Population 635.5.2 Treatment Seeking Population 645.5.3 Diagnosis Population 655.5.4 Prescription Population 665.5.5 Therapeutic Usage Patterns 675.6 Product Analysis 685.6.1 Azilect 685.6.2 Stalevo/Comtan 695.6.3 Madopar 695.6.4 Neupro 695.6.5 Requip/Requip XL 705.6.6 Sifrol/Mirapex 705.6.7 Sinemet 705.7 Drug Pipeline Analysis 706 Global Schizophrenia and Bipolar Disorder Therapeutics Market 736.1 Market Overview 736.2 Market Forecasts 736.3 Average Cost of Therapy 756.4 Volume 766.5 Usage Patterns 776.5.1 Diseased Population 776.5.2 Treatment Seeking Population 786.5.3 Diagnosis Population 796.5.4 Prescription Population 806.5.5 Therapeutic Usage Patterns 816.6 Product Analysis 826.6.1 Abilify 826.6.2 Clozaril 836.6.3 Geodon/Zeldox 836.6.4 Invega 846.6.5 Risperdal/Risperdal Consta 856.6.6 Serdolect 856.6.7 Seroquel 85The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 3/15
  4. 4. Find Industry reports, Company profilesReportLinker and Market Statistics6.6.8 Zyprexa 866.7 Drug Pipeline Analysis 867 Global Epilepsy Therapeutics Market 897.1 Market Overview 897.2 Market Forecasts 897.3 Average Cost of Therapy 907.4 Volume 917.5 Usage Patterns 927.5.1 Diseased Population 927.5.2 Treatment Seeking Population 937.5.3 Diagnosis Population 947.5.4 Prescription Population 957.5.5 Therapeutic Usage Patterns 967.6 Product Analysis 987.6.1 Depakine 987.6.2 Keppra/Keppra XR and Vimpat 987.6.3 Lamictal 997.6.4 Lyrica 1007.6.5 Neurontin 1007.6.6 Tegretol 1007.6.7 Trileptal 1007.6.8 Topamax 1017.6.9 Vimpat 1017.7 Drug Pipeline Analysis 1018 Global MDD, Anxiety and Panic Disorder Therapeutics Market 1038.1 Market Overview 1038.2 Market Forecasts 1038.3 Average Cost of Therapy 1058.4 Volume 1068.5 Usage Patterns 1078.5.1 Diseased Population 1078.5.2 Treatment Seeking Population 1088.5.3 Diagnosis Population 1098.5.4 Prescription Population 1108.5.5 Therapeutic Usage Patterns 1118.6 Product Analysis 1128.6.1 Celexa 1128.6.2 Cipralex 1138.6.3 Cymbalta 1138.6.4 Effexor 1148.6.5 Lexapro 1148.6.6 Pristiq 1148.6.7 Seroxat/Paxil 1148.6.8 Wellbutrin/Wellbutrin XL 1158.6.9 Xanax 1158.6.10 Zoloft 1158.7 Drug Pipeline Analysis 1159 Global ADHD Therapeutics Market 1189.1 Market Overview 1189.2 Market Forecasts 118The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 4/15
  5. 5. Find Industry reports, Company profilesReportLinker and Market Statistics9.3 Average Cost of Therapy 1209.4 Volume 1219.5 Usage Patterns 1219.5.1 Diseased Population 1219.5.2 Treatment Seeking Population 1229.5.3 Diagnosis Population 1239.5.4 Prescription Population 1249.5.5 Therapeutic Usage Patterns 1259.6 Product Analysis 1279.6.1 Adderall/Adderall XR 1279.6.2 Concerta 1279.6.3 Daytrana 1279.6.4 Focalin/Retalin 1289.6.5 Strattera 1299.6.6 Vyvanse 1299.7 Drug Pipeline Analysis 12910 Global Insomnia Therapeutics Market 13110.1 Market Overview 13110.2 Market Forecasts 13110.3 Average Cost of Therapy 13310.4 Volume 13410.5 Usage Patterns 13510.5.1 Diseased Population 13510.5.2 Treatment Seeking Population 13610.5.3 Diagnosis Population 13710.5.4 Prescription Population 13810.5.5 Therapeutic Usage Patterns 13810.6 Product Analysis 14010.6.1 Halcion 14010.6.2 Lunesta 14010.6.3 Rozerem 14110.6.4 Ambien/Stilnox/Ambien CR 14110.6.5 Sonata 14210.7 Drug Pipeline Analysis 14211 Global CNS Therapeutics Market: The US Market 14611.1 Market Overview 14611.2 Market Forecasts 14611.3 Average Cost of Therapy 14811.4 Volume 14911.5 Usage Patterns 14911.5.1 Diseased Population 14911.5.2 Treatment Seeking Population 15111.5.3 Diagnosis Population 15211.5.4 Prescription Population 15311.5.5 Therapeutic Usage Patterns 15412 Global CNS Therapeutics Market: The European Market 15612.1 Market Overview 15612.2 Market Forecasts 15612.3 Average Cost of Therapy 15712.4 Volume 158The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 5/15
  6. 6. Find Industry reports, Company profilesReportLinker and Market Statistics12.5 Usage Patterns 15912.5.1 Diseased Population 15912.5.2 Treatment Seeking Population 16012.5.3 Diagnosis Population 16112.5.4 Prescription Population 16212.5.5 Therapeutic Usage Patterns 16313 Global CNS Therapeutics Market: The Japanese Market 16513.1 Market Overview 16513.2 Market Forecasts 16513.3 Average Cost of Therapy 16613.4 Volume 16813.5 Usage Patterns 16813.5.1 Diseased Population 16813.5.2 Treatment Seeking Population 17013.5.3 Diagnosis Population 17013.5.4 Prescription Population 17113.5.5 Therapeutic Usage Patterns 17214 Global CNS Therapeutics Market: Competitive Landscape 17514.1 Overview 17514.2 Market Share Analysis 17614.3 Competitive Profiling 17814.3.1 AstraZeneca 17914.3.2 Boehringer Ingelheim 17914.3.3 Bristol-Myers Squibb 17914.3.4 Eli Lilly 17914.3.5 GlaxoSmithKline (GSK) 17914.3.6 Johnson & Johnson 18014.3.7 H. Lundbeck A/S 18014.3.8 Novartis 18014.3.9 Pfizer 18114.3.10 Sanofi Aventis 18114.3.11 Shire Pharmaceuticals 18114.3.12 UCB Pharma 18114.3.13 Wyeth 18115 Global CNS Therapeutics Market: Strategic Consolidations 18315.1 Mergers and Acquisitions 18315.1.1 Overview 18315.2 Licensing Agreements 18515.2.1 Preclinical 18715.2.2 Phase I 18815.2.3 Phase II 18915.2.4 Phase III 19015.2.5 Approved 19116 Global CNS Therapeutics Market : Appendix 19316.1 Market Definitions 19316.2 Abbreviations 19316.3 Research Methodology 19316.4 Coverage 19416.5 Secondary Research 19416.6 Primary Research 195The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 6/15
  7. 7. Find Industry reports, Company profilesReportLinker and Market Statistics16.7 Models 19516.8 Forecasts 19516.8.1 Epidemiology-based Forecasting 19516.9 Expert Panel Validation 19716.10 Contact Us 19816.11 Disclaimer 1981.1 List of TablesTable 1: CNS Therapeutics Market, Global, Revenues ($m), 2000-2008 24Table 2: CNS Therapeutics Market, Global, Revenue Forecasts ($m), 2008-2015 24Table 3: CNS Therapeutics Market, Global, Revenue Segmentation ($m), 2000-2008 25Table 4: CNS Therapeutics Market, Global, Revenue Segmentation ($m), 2008-2015 26Table 5: CNS Therapeutics Market, Global, Historical Figures for Average Cost of Therapy ($), 2000-2008 27Table 6: CNS Therapeutics Market, Global, Forecasts for Average Cost of Therapy ($),2008-2015 27Table 7: CNS Therapeutics Market, Global, Historical Figures for Volume (000), 2000-2008 28Table 8: CNS Therapeutics Market, Global, Forecasts for Volume, 2008-2015 28Table 9: CNS Therapeutics Market, Global, Historical Figures for Diseased Population,2000-2008 29Table 10: CNS Therapeutics Market, Global, Forecasts for Diseased Population, 2008-2015 29Table 11: CNS Therapeutics Market, Global, Historical Figures for Treatment Seeking Population, 2000-2008 30Table 12: CNS Therapeutics Market, Global, Forecasts for Treatment Seeking Population, 2008-2015 30Table 13: CNS Therapeutics Market, Global, Historical Figures for Diagnosis Population,2000-2008 31Table 14: CNS Therapeutics Market, Global, Forecasts for Diagnosis Population, 2008-2015 31Table 15: CNS Therapeutics Market, Global, Historical Figures for Prescription Population, 2000-2008 32Table 16: CNS Therapeutics Market, Global, Forecasts for Prescription Population, 2008-2015 32Table 17: CNS Therapeutics Market, Global, Historical Figures for Therapeutic Usage Patterns, 2000-2008 33Table 18: CNS Therapeutics Market, Global, Forecasts for Therapeutic Usage Patterns,2008-2015 34Table 19: CNS Therapeutics Market, Global, Market Drivers, 2008 36Table 20: CNS Therapeutics Market, Global, Market Restraints, 2008 37Table 21: CNS Therapeutics Market, Global, Major Drug Patent Expirations, 2008-2015 38Table 22: CNS Therapeutics Market, Global, Reimbursement Policies of Various 43Table 23: Alzheimers Disease Therapeutics Market, Historical Revenue ($m), 2000-2008 45Table 24: Alzheimers Disease Therapeutics Market, Revenue Forecasts ($m), 2008-2015 45Table 25: Alzheimers Disease Therapeutics Market, Global, Historical Figures for Average Cost of Therapy ($), 2000-2008 46Table 26: Alzheimers Disease Therapeutics Market, Global, Forecasts for Average Cost of Therapy ($), 2008-2015 46Table 27: Alzheimers Disease Therapeutics Market, Global, Historical Figures for Volume, 2000-2008 47Table 28: Alzheimers Disease Therapeutics Market, Global, Historical Figures for Volume, 2008-2015 47Table 29: Alzheimers Disease Therapeutics Market, Global, Historical Figures for Diseased Population, 2000-2008 48Table 30: Alzheimers Disease Therapeutics Market, Global, Forecasts for Diseased Population, 2008-2015 49Table 31: Alzheimers Disease Therapeutics Market, Global, Historical Figures for Treatment Seeking Population, 2000-2008 49Table 32: Alzheimers Disease Therapeutics Market, Global, Forecasts for Treatment Seeking Population, 2008-2015 50Table 33: Alzheimers Disease Therapeutics Market, Global, Historical Figures for Diagnosis Population, 2000-2008 50Table 34: Alzheimers Disease Therapeutics Market, Global, Forecasts for Diagnosis Population, 2008-2015 51Table 35: Alzheimers Disease Therapeutics Market, Global, Historical Figures for Prescription Population, 2000-2008 51Table 36: Alzheimers Disease Therapeutics Market, Global, Forecasts for Prescription Population, 2008-2015 52Table 37: Alzheimers Disease Therapeutics Market, Global, Historical Figures for Therapeutic Usage Patterns, 2000-2008 53The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 7/15
  8. 8. Find Industry reports, Company profilesReportLinker and Market StatisticsTable 38: Alzheimers Disease Therapeutics Market, Global, Forecasts for Therapeutic Usage Patterns, 2008-2015 53Table 39: Alzheimers Disease Therapeutics Market, Global, Major Manufacturers and Drugs, 2008 53Table 40: Alzheimers Disease Therapeutics Market, Global, Clinical Trials Pipeline, 2008 56Table 41: Parkinsons Disease Therapeutics Market, Global, Historical Revenues ($m),2000-2008 60Table 42: Parkinsons Disease Therapeutics Market, Global, Revenue Forecasts ($m),2008-2015 61Table 43: Parkinsons Disease Therapeutics Market, Global, Historical Figures for Average Cost of Therapy ($), 2000-2008 61Table 44: Parkinsons Disease Therapeutics Market, Global, Forecasts for Average Cost of Therapy ($), 2008-2015 62Table 45: Parkinsons Disease Therapeutics Market, Global, Historical Figures for Volume, 2000-2008 62Table 46: Parkinsons Disease Therapeutics Market, Global, Forecasts for Volume, 2008-2015 63Table 47: Parkinsons Disease Therapeutics Market, Global, Historical Figures for Diseased Population, 2000-2008 64Table 48: Parkinsons Disease Therapeutics Market, Global, Forecasts for Diseased Population, 2008-2015 64Table 49: Parkinsons Disease Therapeutics Market, Global, Historical Figures for Treatment Seeking Population, 2000-2008 65Table 50: Parkinsons Disease Therapeutics Market, Global, Forecasts for Treatment Seeking Population, 2008-2015 65Table 51: Parkinsons Disease Therapeutics Market, Global, Historical Figures for Diagnosis Population, 2000-2008 66Table 52: Parkinsons Disease Therapeutics Market, Global, Forecasts for Diagnosis Population, 2008-2015 66Table 53: Parkinsons Disease Therapeutics Market, Global, Historical Figures for Prescription Population, 2000-2008 67Table 54: Parkinsons Disease Therapeutics Market, Global, Forecasts for Prescription Population, 2008-2015 67Table 55: Parkinsons Disease Therapeutics Market, Global, Historical Figures for Therapeutic Usage Patterns, 2000-2008 68Table 56: Parkinsons Disease Therapeutics Market, Global, Forecasts for Therapeutic Usage Patterns, 2008-2015 68Table 57: Parkinsons Disease Therapeutics Market, Global, Major Manufacturers and Drugs, 2008 68Table 58: Parkinsons Disease Therapeutics Market, Global, Clinical Trials Pipeline, 2008 71Table 59: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Historical Revenues ($m), 2000-2008 74Table 60: Schizophrenia and Bipolar Disorder Therapeutics Market, Global,, Revenue Forecasts ($m), 2008-2015 75Table 61: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Historical Figures for Average Cost of Therapy ($),2000-2008 76Table 62: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Forecasts for Average Cost of Therapy ($), 2008-2015 76Table 63: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Historical Figures for Volume, 2000-2008 77Table 64: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Forecasts for Volume, 2008-2015 77Table 65: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Historical Figures for Diseased Population, 2000-2008 78Table 66: Schizophrenia and Bipolar Disorder Therapeutics Market, Forecasts for Diseased Population, 2008-2015 78Table 67: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Historical Figures for Treatment Seeking Population,2000-2008 79Table 68: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Forecasts for Treatment Seeking Population, 2008-201579Table 69: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Historical Figures for Diagnosis Population, 2000-2008 80Table 70: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Forecasts for Diagnosis Population, 2008-2015 80Table 71: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Historical Figures for Prescription Population, 2000-200881Table 72: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Forecasts for Prescription Population, 2008-2015 81Table 73: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Historical Figures for Therapeutic Usage Patterns,2000-2008 82Table 74: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Forecasts for Therapeutic Usage Patterns, 2008-2015 82Table 75: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Major Manufacturers and Drugs, 2008 83Table 76: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Clinical Trials Drug Portfolio, 2008 86Table 77: Epilepsy Therapeutics Market, Global, Historical Revenues ($m), 2000-2008 90Table 78: Epilepsy Therapeutics Market, Global, Revenue Forecasts ($m), 2008-2015 90Table 79: Epilepsy Therapeutics Market, Global, Historical Figures for Average Cost of Therapy ($), 2000-2008 91Table 80: Epilepsy Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015 91The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 8/15
  9. 9. Find Industry reports, Company profilesReportLinker and Market StatisticsTable 81: Epilepsy Therapeutics Market, Global, Historical Figures for Volume, 2000-2008 92Table 82: Epilepsy Therapeutics Market, Global, Forecasts for Volume, 2008-2015 92Table 83: Epilepsy Therapeutics Market, Global, Historical Figures for Diseased Population, 2000-2008 93Table 84: Epilepsy Therapeutics Market, Global, Forecasts for Diseased Population, 2008-2015 93Table 85: Epilepsy Therapeutics Market, Global, Historical Figures for Treatment Seeking Population, 2000-2008 94Table 86: Epilepsy Therapeutics Market, Global, Forecasts for Treatment Seeking Population, 2008-2015 94Table 87: Epilepsy Therapeutics Market, Global, Historical Figures for Diagnosis Population, 2000-2008 95Table 88: Epilepsy Therapeutics Market, Global, Forecasts for Diagnosis Population,2008-2015 95Table 89: Epilepsy Therapeutics Market, Global, Historical Figures for Prescription Population, 2000-2008 96Table 90: Epilepsy Therapeutics Market, Forecasts for Prescription Population, 2008-2015 96Table 91: Epilepsy Therapeutics Market, Global, Historical Figures for Therapeutic Usage Patters, 2000-2008 97Table 92: Epilepsy Therapeutics Market, Global, Forecasts for Therapeutic Usage Patterns, 2008-2015 97Table 93: Epilepsy Therapeutics Market, Global, Major Manufacturers and Drugs, 2008 98Table 94: Epilepsy Therapeutics Market, Global, Clinical Trials Drug Portfolio, 2008 101Table 95: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Historical Revenues ($m), 2000-2008 104Table 96: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Revenue Forecasts ($m), 2008-2015 104Table 97: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Historical Figures for Average Cost of Therapy ($),2000-2008 105Table 98: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Forecasts for Average Cost of Therapy ($), 2008-2015 105Table 99: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Historical Figures for Volume, 2000-2008 106Table 100: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Forecasts for Volume, 2008-2015 106Table 101: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Historical Figures for Diseased Population, 2000-2008 107Table 102: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Forecasts for Diseased Population, 2008-2015 108Table 103: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Historic Figures for Treatment Seeking Population,2000-2008 108Table 104: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Forecasts for Treatment Seeking Population, 2008-2015109Table 105: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Historical Figures for Diagnosis Population, 2000-2008109Table 106: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Forecasts for Diagnosis Population, 2008-2015 110Table 107: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Historical Figures for Prescription Population, 2000-2008110Table 108: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Forecasts for Prescription Population, 2008-2015 111Table 109: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Historical Figures for Therapeutic Usage Patterns,2000-2008 112Table 110: MDD, Anxiety Panic Disorder Therapeutics Market, Global, Forecasts for Therapeutic Usage Patterns, 2008-2015 112Table 111: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Major Manufacturers and Drugs, 2008 112Table 112: Global MDD, Panic and Anxiety Disorder Therapeutics Market, Clinical Trials Drug Portfolio, 2008 115Table 113: Global ADHD Therapeutics Market, Historical Revenues ($m), 2000-2008 119Table 114: Global ADHD Therapeutics Market, Revenues Forecasts ($million), 2008-2015 119Table 115: ADHD Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008 120Table 116: ADHD Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015 120Table 117: Global ADHD Therapeutics Market, Historical Figures for Volume, 2000-2008 121Table 118: Global ADHD Therapeutics Market, Forecasts for Volume, 2008-2015 121Table 119: Global ADHD Therapeutics Market, Historical Figures for Diseased Population,2000-2008 122Table 120: Global ADHD Therapeutics Market, Forecasts for Diseased Population, 2008-2015 122Table 121: Global ADHD Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 123Table 122: Global ADHD Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 123The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 9/15
  10. 10. Find Industry reports, Company profilesReportLinker and Market StatisticsTable 123: Global ADHD Therapeutics Market, Historical Figures for Diagnosis Population, 2000-2008 124Table 124: Global ADHD Therapeutics Market, Forecasts for Diagnosis Population, 2008-2015 124Table 125: Global ADHD Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 125Table 126: Global ADHD Therapeutics Market, Forecasts for Prescription Population,2008-2015 125Table 127: Global ADHD Therapeutics Market, Historical Figures for Therapeutic Usage Patterns, 2000-2008 126Table 128: Global ADHD Therapeutics Market, Forecasts for Therapeutic Usage Patterns,2008-2015 126Table 129: Global ADHD Therapeutics Market, Major Manufacturers and Drugs, 2008 127Table 130: Global Insomnia Therapeutics Market, Historical Revenues ($m), 2000-2008 132Table 131: Global Insomnia Therapeutics Market, Revenue Forecasts ($m), 2008-2015 132Table 132:Global Insomnia Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008 133Table 133: Global Insomnia Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015 133Table 134: Insomnia Therapeutics Market, Historical Figures for Volume, 2000-2008 134Table 135: Insomnia Therapeutics Market, Forecasts for Volume, 2008-2015 134Table 136: Global Insomnia Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 135Table 137: Global Insomnia Therapeutics Market, Forecasts for Diseased Population,2008-2015 135Table 138: Global Insomnia Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 136Table 139: Insomnia Therapeutics Market, Forecasts for Treatment Seeking Population,2008-2015 136Table 140: Global Insomnia Therapeutics Market,Historical Figures for Diagnosis Population, 2000-2008 137Table 141: Global Insomnia Therapeutics Market, Forecasts for Diagnosis Population,2008-2015 137Table 142: Global Insomnia Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 138Table 143: Global Insomnia Therapeutics Market, Forecasts for Prescription Population,2008-2015 138Table 144: Global Insomnia Therapeutics Market, Historical Figures for Therapeutic Usage Patterns, 2000-2008 139Table 145: Global Insomnia Therapeutics Market, Forecasts for Therapeutic Usage Patterns, 2008-2015 139Table 146: Global Insomnia Therapeutics Market, Major Manufacturers and Drugs, 2008 140Table 147: Insomnia Therapeutics Market, Clinical Trials Pipeline, 2008 142Table 148: CNS Therapeutics Market, US, Historical Revenues ($m), 2000-2008 147Table 149: CNS Therapeutics Market, US, Revenue Forecasts ($m), 2008-2015 147Table 150: CNS Therapeutics Market, US, Historical Figures for the Average Cost of Therapy ($), 2000-2008 148Table 151: CNS Therapeutics Market, US, Forecasts for the Average Cost of Therapy ($),2008-2015 148Table 152: CNS Therapeutics Market, US, Historical Figures for Volume, 2000-2008 149Table 153: CNS Therapeutics Market, US, Forecasts for Volume, 2008-2015 149Table 154: CNS Therapeutics Market, US, Historical Figures for Diseased Population,2000-2008 150Table 155: CNS Therapeutics Market, US, Forecasts for Diseased Population, 2008-2015 151Table 156: CNS Therapeutics Market, US, Historical Figures for Treatment Seeking Population, 2000-2008 151Table 157: CNS Therapeutics Market, US, Forecasts for Treatment Seeking Population,2008-2015 152Table 158: CNS Therapeutics Market, US, Historical Figures for Diagnosis Population,2000-2008 153Table 159: CNS Therapeutics Market, US, Forecasts for Diagnosis Population, 2008-2015 153Table 160: CNS Therapeutics Market, US, Historical Figures for Prescription Population,2000-2008 154Table 161:CNS Therapeutics Market, US, Forecasts for Prescription Population, 2008-2015 154The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 10/15
  11. 11. Find Industry reports, Company profilesReportLinker and Market StatisticsTable 162:CNS Therapeutics Market, US, Historical Figures for Usage Patterns, 2000-2008 155Table163: CNS Therapeutics Market, US, Forecasts for Usage Patterns, 2008-2015 155Table 164: CNS Therapeutics Market, Europe, Historical Revenues ($m), 2000-2008 157Table 165: CNS Therapeutics Market, Europe, Revenue Forecasts ($m), 2008-2015 157Table 166: CNS Therapeutics Market, Europe, Historical Figures for Average Cost of Treatment, 2000-2008 158Table 167: CNS Therapeutics Market, Europe, Forecasts for Average Cost of Treatment,2008-2015 158Table 168: CNS Therapeutics Market, Europe, Historical Figures for Volume, 2000-2008 159Table 169: CNS Therapeutics Market, Europe, Forecasts for Volume, 2008-2015 159Table 170: CNS Therapeutics Market, Europe, Historical Figures for Diseased Population,2000-2008 160Table 171: CNS Therapeutics Market, Europe, Forecasts for Diseased Population, 2008-2015 160Table 172: CNS Therapeutics Market, Europe, Historical Figures for Treatment Seeking Population, 2000-2008 161Table173: CNS Therapeutics Market, Europe, Forecasts for Treatment Seeking Population, 2008-2015 161Table 174: CNS Therapeutics Market, Europe, Historical Figures for Diagnosis Population, 2000-2008 162Table 175: CNS Therapeutics Market, Europe, Forecasts for Diagnosis Population, 2008-2015 162Table 176: CNS Therapeutics Market, Europe, Historical Figures for Prescription Population, 2000-2008 163Table 177: CNS Therapeutics Market, Europe, Forecasts for Prescription Population, 2008-2015 163Table 178: CNS Therapeutics Market, Europe, Historical Figures for Therapeutic Usage Patterns, 2000-2008 164Table 179: CNS Therapeutics Market, Europe, Forecasts for Therapeutic Usage Patterns,2008-2015 164Table 180: CNS Therapeutics Market, Japan, Historical Revenues ($m), 2000-2008 166Table 181:CNS Therapeutics Market, Japan, Revenue Forecasts ($m), 2008-2015 166Table 182: CNS Therapeutics Market, Japan, Historical Figures for Average Cost of Therapy ($), 2000-2008 167Table 183: CNS Therapeutics Market, Japan, Forecasts for Average Cost of Therapy ($),2008-2015 167Table 184: CNS Therapeutics Market, Japan, Historical Figures for Volume, 2000-2008 168Table 185: CNS Therapeutics Market, Japan, Forecasts for Volume, 2008-2015 168Table 186: CNS Therapeutics Market, Japan, Historical Figures for Diseased Population,2000-2008 169Table 187: CNS Therapeutics Market, Japan, Forecasts for Diseased Population, 2008-2015 169Table 188: CNS Therapeutics Market, Japan, Historical Figures for Treatment Seeking Population, 2000-2008 170Table 189: CNS Therapeutics Market, Japan, Forecasts for Treatment Seeking Population, 2008-2015 170Table 190: CNS Therapeutics Market, Japan, Historical Figures for Diagnosis Population,2000-2008 171Table 191: CNS Therapeutics Market, Japan, Forecasts for Diagnosis Population, 2008-2015 171Table 192: CNS Therapeutics Market, Japan, Historical Figures for Prescription Population, 2000-2008 172Table 193: CNS Therapeutics Market, Japan, Forecasts for Prescription Population, 2008-2015 172Table 194: CNS Therapeutics Market, Japan, Historical Figures for Therapeutic Usage Patterns, 2000-2008 173Table 195: CNS Therapeutics Market, Japan, Forecasts for Therapeutic Usage Patterns,2008-2015 174Table 196: CNS Therapeutics Market, Global, Licensing Agreements for Drugs in the Preclinical Stage, 2008 187Table 197: CNS Therapeutics Market, Global, Licensing Agreements for Drugs in Phase I Stage, 2008 188Table 198: CNS Therapeutics Market, Global, Licensing Agreements for Drugs in the Phase II Stage, 2008 189Table 199: CNS Therapeutics Market, Global, Licensing Agreements for Drugs in the Phase III Stage, 2008 190Table 200: CNS Therapeutics Market, Global, Licensing Agreements for Approved Drugs, 2008 1911.2 List of FiguresFigure 1: CNS Therapeutics Market, Global, Market Overview, 2008 22The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 11/15
  12. 12. Find Industry reports, Company profilesReportLinker and Market StatisticsFigure 2: CNS Therapeutics Market, Global, Key Geographical Trends, 2008 23Figure 3: CNS Therapeutics Market, Global, Revenue Forecasts ($bn), 2000-2015 24Figure 4: CNS Therapeutics Market, Global, Revenue Split ($bn), 2000-2015 25Figure 5: CNS Therapeutics Market, Global, Market Share of Major Disease Sectors, 2008 26Figure 6: Global CNS Therapeutics Market, Average Cost of Therapy ($), 2000-2015 27Figure 7: CNS Therapeutics Market, Global, Forecasts for Volume, 2000-2015 28Figure 8: CNS Therapeutics Market, Global, Forecasts for Diseased Population, 2000-2015 29Figure 9: CNS Therapeutics Market, Global, Forecasts for Treatment Seeking Population,2000-2015 30Figure 10: CNS Therapeutics Market, Global, Forecasts for Diagnosis Population, 2000-2015 31Figure 11: CNS Therapeutics Market, Global, Forecasts for Prescription Population, 2000-2015 32Figure 12: CNS Therapeutics Market, Global, Forecasts for Therapeutic Usage Patterns,2000-2015 33Figure 13: CNS Therapeutics Market, Global, Geographical Distribution of Revenues ($bn), 2000-2015 34Figure 14: CNS Therapeutics Market, Global, Geographical Comparison of Market Competition, 2008 35Figure 15: CNS Therapeutics Market, Global, Market Indicators, 2008 36Figure 16: CNS Therapeutics Market, Global, Analysis of Unmet Needs for Major Disease Sectors, 2008 39Figure 17: CNS Therapeutics Market, Global, Key Market Events, 2008-2015 41Figure 18: Alzheimers Disease Therapeutics Market, Global, Revenue Forecasts ($m),2000-2015 44Figure 19: Alzheimers Disease Therapeutics Market, Global, Average Cost of Therapy ($), 2000-2015 46Figure 20: Alzheimers Disease Therapeutics Market, Global, Global,Forecasts for Volume, 2000-2015 47Figure 21: Alzheimers Disease Therapeutics Market, Global, Forecasts for Diseased Population, 2000-2015 48Figure 22: Alzheimers Disease Therapeutics Market, Global, Forecasts for Treatment Seeking Population, 2000-2015 49Figure 23: Alzheimers Disease Therapeutics Market, Global, Forecasts for Diagnosis Population, 2000-2015 50Figure 24: Alzheimers Disease Therapeutics Market, Global, Forecasts for Prescription Population, 2000-2015 51Figure 25: Alzheimers Therapeutics Market, Global, Forecasts for Therapeutic Usage Patterns, 2000-2015 52Figure 26: Alzheimers Disease Therapeutics Market, Global, Market Share of Major Therapeutic Drugs, 2008 54Figure 27: Alzheimers Disease Therapeutics Market, Global, Historical Revenues of Major Drugs ($m), 2006-2008 55Figure 28: Alzheimers Disease Therapeutics Market, Global, Share Assessment of Molecules Under Stages of Clinical Development,2008 57Figure 29: Alzheimers Disease Therapeutics Market, Global, Clinical Trials Drug Portfolio, 2008 57Figure 30: Alzheimers Disease Therapeutics Market, Global, Major Manufacturers and their Pipeline Portfolio, 2008 58Figure 31: Parkinsons Disease Therapeutics Market, Global, Revenue Forecasts ($m),2000-2015 60Figure 32: Parkinsons Disease Therapeutics Market, Global, Average Cost of Therapy ($), 2000-2015 61Figure 33: Parkinsons Disease Therapeutics Market, Global, Forecasts for Volume, 2000-2015 62Figure 34: Parkinsons Disease Therapeutics Market, Global, Forecasts for Diseased Population, 2000-2015 63Figure 35: Parkinsons Disease Therapeutics Market, Global, Forecasts for Treatment Seeking Population, 2000-2015 64Figure 36: Parkinsons Disease Therapeutics Market, Global, Forecasts for Diagnosis Population, 2000-2015 65Figure 37: Parkinsons Disease Therapeutics Market, Global, Forecasts for Prescription Population, 2000-2015 66Figure 38: Parkinsons Disease Therapeutics Market, Global, Forecasts for Therapeutic Usage Patterns, 2000-2015 67Figure 39: Parkinsons Disease Therapeutics Market, Global, Market Share of Major Therapeutic Drugs, 2008 69Figure 40: Parkinsons Disease Therapeutics Market, Global, Historic Revenues of Major Drugs ($m), 2006-2008 70Figure 41: Parkinsons Disease Therapeutics Market, Global, Share Assessment of Molecules Under Stages of Development, 200871Figure 42: Parkinsons Disease Therapeutics Market, Global, Clinical Trials Drug Portfolio, 2008 72Figure 43: Parkinsons Disease Therapeutics Market, Global, Major Manufacturers and their Pipeline Portfolio, 2008 72Figure 44: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Revenue Forecasts ($m), 2000-2015 74Figure 45: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Average Cost of Therapy ($), 2000-2015 75The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 12/15
  13. 13. Find Industry reports, Company profilesReportLinker and Market StatisticsFigure 46: Schizophrenia and Bipolar Disorder Therapeutics Markets, Global, Forecasts for Volume, 2000-2015 76Figure 47: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Forecasts for Diseased Population, 2000-2015 77Figure 48: Schizophrenia and Bipolar Disorder Therapeutics Market, GlobThe Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 13/15
  14. 14. Find Industry reports, Company profilesReportLinker and Market Statistics Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarkin g, Product Pipeline and Deals Analysis Product Formats Please select the product formats and the quantity you require. 1 User License--USD 3 500.00 Quantity: _____ Site License--USD 7 000.00 Quantity: _____ Corporate License--USD 10 500.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 14/15
  15. 15. Find Industry reports, Company profilesReportLinker and Market Statistics Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 15/15

×